Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal recognition particle receptor subunit alpha (SRPRA) is the peripheral membrane GTPase subunit of the signal recognition particle (SRP) receptor, a heterodimeric complex associated with the rough endoplasmic reticulum (ER) in eukaryotic cells[1][5]. This protein, together with its partner subunit SRP receptor beta (SRPRB), mediates the GTP-dependent targeting and docking of ribosome-nascent chain complexes—specifically those containing secretory or membrane proteins recognized by signal sequences—to the ER membrane via the SRP[1][2][3]. SRPRA interacts directly with the SRP54 subunit of the SRP and is necessary for the transfer of the nascent protein from SRP to the protein translocation apparatus (translocon) within the ER, thus playing a critical role in proper protein sorting and secretion[1][2][5]. Loss or dysfunction of SRPRA disrupts protein secretion, leads to defects in cell growth, and has been implicated in congenital neutropenia and related disorders[4][5].
Not directly drug-targeted; the primary mechanism is GTP-dependent interaction with SRP and mediation of protein translocation into the endoplasmic reticulum.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal recognition particle receptor subunit alpha (SRPRA).